// App-Quantinova.ai

4333 : Identification and optimization of the first highly selective GLUT-1 inhibitors

Researchers

Presenter

  • Marcus Bauser

Principal Investigators

  • Bernd Buchmann

  • Holger Siebeneicher

  • Arwed Cleve

  • Hartmut Rehwinkel

  • Roland Neuhaus

  • Iring Heisler

  • Thomas Mueller

  • Charlotte Christine Kopitz

Medical Centers

  • Bayer HealthCare, Berlin, Germany.

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved